Ark, Cathie and 10X Genomics

Cathie Wood's Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats Up
Jan. 30, 2025 Cathie Wood-led Ark Invest sold $10.4 million worth of Palantir shares through its flagship fund.
Cathie Wood's ARK buys Qualcomm and 10X Genomics stock
Cathie Wood's ARK ETFs have made their daily trades public for Wednesday, 29 January 2025, showcasing a series of strategic moves in the tech and biotech sectors. The most significant purchase was in 10X Genomics Inc (NASDAQ:TXG),
Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics today
EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Cathie Wood buys $16.6 million of wavering tech stocks
Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a disruptive impact. She isn’t afraid to buy them on the way down — or up. Sometimes her strategy works: The flagship Ark Innovation ETF (ARKK) has returned 9% this year as of Jan.
Cathie Wood’s ARK Investment buys 172K shares of Teradyne today
EST Cathie Wood’s ARK Investment buys 172K shares of Teradyne (TER) todayInvest with Confidence: Follow TipRanks' Top Wall Street
Investing1mon
Cathie Wood's ARK ETF adjusts, adds 10X Genomics, sells Rocket Lab
Cathie Wood's ARK ETF published their daily trades for Monday ... The largest transaction of the day was the purchase of 78,181 shares of 10X Genomics Inc (NASDAQ:TXG), valued at approximately ...
Business Insider3d
Cathie Wood’s ARK Investment buys 247K shares of 10x Genomics today
20:04 EST Cathie Wood’s ARK Investment buys 247K shares of 10x Genomics (TXG) today Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.
Nasdaq1mon
Cathie Wood’s ARK Investment buys 25K shares of 10x Genomics today
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...